Coke’s Quarterly Revenue and Volumes Fall but Still Beat Expectations
Coca-Cola Co. said Wednesday its third-quarter revenue fell as sales volumes flattened or declined around the world
All Posts in "Market Watch"
Starbucks Reports Weak Quarterly Results Despite the Arrival of Pumpkin Spice Latte Season
It’s been a disappointing start to Pumpkin Spice Latte season for Starbucks
Wall Street Slumps to a Rare 3-Day Losing Streak
U.S. stocks fell as more steam came out of Wall Street’s huge, record-breaking rally
Icon Shares Drop 17% After Missing on 3Q Results
Shares of Icon slid in postmarket trading after it reported revenue and earnings-per-share results that missed estimates.
Leading Economic Gauge Falls on Global Weakness
The U.S. economy is outperforming expectations as the race for the White House enters its final days.
Horizon Robotics Shares Jump in Hong Kong Trading Debut
Horizon Robotics surged in its trading debut after one of Hong Kong’s largest listings this year, adding to optimism that the city’s IPO market is making a comeback.
Fed: Economy Growing, Labor Market in Balance
The findings from the Federal Reserve reflect an economy that is neither too hot or too cold.
Starbucks’ latest financials sink shares, as CEO says it’s ‘harder to be a customer than it should be’
New CEO Brian Niccol calls for simplifying menu. But company warns turnaround ‘will take time,’ and an analyst says a ‘reality check’ is needed.
Wall Street Barely Budges as GM’s Best Day in Years Offsets GE Aerospace Tumble
U.S. stock indexes barely budged after a quiet day of mixed trading
Taxpayers Will Get Bigger Standard Deductions in 2025, but With Smaller Boosts Than Recent Years
U.S. taxpayers will again see higher standard deductions for 2025, allowing them to shield more of their money from taxation on future returns
Novartis, Versant hope to repeat Chinook’s success by arming kidney biotech Borealis with $150M
Roche ramps up lab testing capacity for mpox worldwide following WHO declaration
BioMarin creates new-look R&D and deal teams with Roche’s Sabry, Amgen’s Friberg
FDA rejects Regeneron’s blood cancer bispecific, delaying would-be challenger to J&J and Pfizer
Researchers receive $6.9M grant for tau-targeting drug with potential in Alzheimer’s and beyond
BridgeBio launches another offshoot with $300M and early genetic disease programs
PreciseDx picks up $20.7M to advance AI-based breast cancer risk assessment
Medtech VC investment held steady in Q2 with $3.3B of deal value: PitchBook
Walmart Becomes Latest – and Biggest – Company to Roll Back Its DEI Policies
‘Buy Now, Pay Later’ Is More Popular Than Ever. It Can Cost More Than You Think